Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShrestha, Surya Kumari-
dc.contributor.authorKhadka, Sujan-
dc.contributor.authorRayamajhee, Binod-
dc.contributor.authorThapa, Alina-
dc.contributor.authorSharma, Suprina-
dc.contributor.authorShrestha, Basudha-
dc.contributor.authorPoudel, Pramod-
dc.identifier.citationShresthaS. K., KhadkaS., RayamajheeB., ThapaA., SharmaS., ShresthaB., & PoudelP. (2022). Lower Susceptibility to Fluoroquinolones and a gyrA Gene Mutation in Salmonella Typhi Isolates from Enteric Fever Patients . Journal of Nepal Health Research Council, 20(02), 517-523.
dc.identifier.issnPrint ISSN: 1727-5482; Online ISSN: 1999-6217-
dc.descriptionOriginal Articleen_US
dc.description.abstractAbstract Background: Enteric fever remains a major cause of morbidity and mortality in Nepal. The emergence of multi-drug resistant Salmonella is a challenge to the clinician to care for patients with enteric fever. This study assessed the antibiotic susceptibility of Salmonella Typhi isolated from enteric fever and the presence of gyrA? ?gene mutation at ser83 of S. Typhi. Methods: Blood samples (n = 834) from suspected enteric fever patients were collected and cultured to identify Salmonella Typhi. Antimicrobial sensitivity test was performed by the modified Kirby Bauer disc diffusion method. The minimum ?inhibitory concentration (MIC) tests for ofloxacin and ciprofloxacin were examined by the agar dilution method. The gyrA gene was amplified by PCR and restriction enzyme digestion was performed to evaluate the ser83 mutation. Results: Among 824 blood samples analyzed, 5.1% (42/824) were culture positive for S. Typhi. First-line antibiotics chloramphenicol and co-trimoxazole showed higher in-vitro efficacy compared to amoxicillin. Macrolides (azithromycin) and third-generation cephalosporins (ceftriaxone, cefixime, and cefotaxime) were highly effective against S. Typhi. Nalidixic acid resistance (NAR) was observed in 95.2% (40/42) isolates, among them, all (40/40) isolates harbored mutant gyrA gene at ser83. However, none of the nalidixic acid-sensitive Salmonella? isolates was positive for gyrA? mutation at ser83. Conclusions: This study showed decreased susceptibility to fluoroquinolones and the presence of gyrA? mutation at ser83 position in majority of S. Typhi isolates which highlights the importance of alternate drugs as empirical therapy for the treatment of enteric fever patients. So, the clinician should focus on prescribing conventional first-line antibiotics for the treatment of typhoid patients after higher cohort and extended follow-up studies. Keywords: Antibiotics susceptibility; fluoroquinolones; gyrA? gene; nalidixic acid; Salmonella? Typhien_US
dc.publisherNepal Health Research Councilen_US
dc.relation.ispartofseriesApril-June, 2022;4245-
dc.subjectAntibiotics susceptibilityen_US
dc.subjectFluoroquinolones; gyrAen_US
dc.subjectGene; nalidixic acid; Salmonella? Typhien_US
dc.titleLower Susceptibility to Fluoroquinolones and a gyrA Gene Mutation in Salmonella Typhi Isolates from Enteric Fever Patientsen_US
dc.typeJournal Articleen_US
Appears in Collections:Vol 20 No 02 Issue 55 April-June, 2022

Files in This Item:
File Description SizeFormat 
4245-Manuscript-29709-1-10-20221103.pdfFull Article.721.87 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.